Last reviewed · How we verify
3-Beta-hydroxy-delta-5-C27-steroid dehydrogenase deficiency
Approved treatments
- Cholbam · Mirum
Cholbam works by binding to the G-protein coupled bile acid receptor 1, which helps regulate bile acid levels in the body. - Cholbam · Mirum Pharmaceuticals, Inc.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- 3-Beta-hydroxy-delta-5-C27-steroid dehydrogenase deficiency patent landscape — cliff calendar, originator estates, attackable patents
- 3-Beta-hydroxy-delta-5-C27-steroid dehydrogenase deficiency treatment landscape brief
- 3-Beta-hydroxy-delta-5-C27-steroid dehydrogenase deficiency treatment updates RSS
Frequently asked questions about 3-Beta-hydroxy-delta-5-C27-steroid dehydrogenase deficiency
What drugs treat 3-Beta-hydroxy-delta-5-C27-steroid dehydrogenase deficiency?
Tracked treatments include Cholbam.
What is the treatment for 3-Beta-hydroxy-delta-5-C27-steroid dehydrogenase deficiency?
Standard treatment for 3-Beta-hydroxy-delta-5-C27-steroid dehydrogenase deficiency includes Cholbam. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: 3-Beta-hydroxy-delta-5-C27-steroid dehydrogenase deficiency patent cliff · 3-Beta-hydroxy-delta-5-C27-steroid dehydrogenase deficiency CI report
- Treatment: Cholbam · Mirum
- Treatment: Cholbam · Mirum Pharmaceuticals, Inc.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing